Novast
With state-of-the-art facilities and a pioneering team, we bring advanced generic drugs to the U.S. market through strategic collaborations.
51-200 employees · est. 2005
Novast is the older company (2006 vs 2005); Novast is the larger of the two.
Side-by-Side Comparison
| Metric | epinamics GmbH | Novast |
|---|---|---|
| Founded | ||
| Founded | 2006 | 2005 older |
| Headquarters | ||
| Headquarters | Berlin, Germany | Not tracked yet |
| Employees | ||
| Employees | 3 | 51-200 larger |
| Industry | ||
| Industry | Not tracked yet | Health Care, Manufacturing, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Equity Crowdfunding | Series Unknown |
| Total Funding | ||
| Total Funding | $175.25K | $1.50B |
| Funding Rounds | ||
| Funding Rounds | 1 | 7 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Drug Delivery Technology, Transdermal Applications, Pharmaceutical Research, Development, Cosmetic Products, Veterinary Products, Platform Technology, Polymer-based Technology, Pharmaceutical Ingredients, Dermal Products, Transdermal Products, Innovative Medicine, Research & Development, Supergenerics, Metered Dose Applications | Pharmaceuticals, Generic Drugs, Research And Development, Drug Manufacturing, US Market Entry, CGMP Facilities, Patent Application, Drug Delivery Technology, Dosage Forms, US Sales Channels, Collaborations, Innovation, Value-Added Drugs, China-US Collaboration, Market Expansion |
| Website | ||
| Website | epinamics.com | novast.cn |
About epinamics GmbH
epinamics GmbH is a Berlin-based research and development company established in 2006. The company specializes in innovative drug delivery technology for dermal and transdermal applications of cosmetic, pharmaceutical, and veterinary products. Their proprietary technology, Liqui-Patch, is a polymer-...
About Novast
Novast leverages its state-of-the-art facilities and a pioneering team to introduce advanced generic drugs to the U.S. market through strategic collaborations. Specializing in the research, development, and production of value-added generic drugs, Novast targets the U.S. pharmaceutical market in par...
We will tell you when either one moves
BounceWatch watches epinamics GmbH and Novast for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at epinamics GmbH and Novast — by email.
Frequently Asked Questions
Compare epinamics GmbH with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at epinamics GmbH on 12 Sep 2024, and Novast on 26 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
